| Literature DB >> 16951367 |
María E Alvarez1, Juan I Fuxman Bass, Jorge R Geffner, Paula X Fernández Calotti, Mónica Costas, Omar A Coso, Romina Gamberale, Mónica E Vermeulen, Gabriela Salamone, Diego Martinez, Tamara Tanos, Analía S Trevani.
Abstract
We have previously shown that bacterial DNA activates human neutrophils in a CpG-independent manner. In this study, we have characterized the signaling pathways involved in the activation mechanism. We found that p38 MAPK, ERK1/2, and JNK pathways, as well as the PI3K/Akt pathway, are activated by bacterial DNA. We also determined that bacterial DNA induces NF-kappaB and AP-1 activation. When analyzing the role of these pathways on neutrophil functions, we observed that up-regulation of CD11b triggered by bacterial DNA was decreased by pharmacological inhibitors of the p38 MAPK, ERK1/2, and JNK, whereas stimulation of IL-8 release was dependent on p38, ERK1/2, and NF-kappaB. Moreover, we found that IL-8 production was markedly enhanced by inhibition of JNK, suggesting that this pathway negatively modulates NF-kappaB-dependent transcription. We also observed that bacterial DNA stimulated IL-1R-associated kinase-1 kinase activity and its partial degradation. Finally, we determined that bacterial DNA stimulated CD11b up-regulation in TLR9(-/-) but not in MyD88(-/-) mouse neutrophils, supporting that bacterial DNA induces neutrophil activation through a TLR9-independent and MyD88-dependent pathway.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16951367 DOI: 10.4049/jimmunol.177.6.4037
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422